VYOME HOLDINGS, INC. Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price
VYOME HOLDINGS, INC. (HIND) reported Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price of $37.74 per share for the 12-month period ending 2020-12-31, per its 10-K filed 2021-03-12.
Discontinued › Notes › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice · last filed 2021-03-12
- VYOME HOLDINGS, INC. share-based compensation arrangements by share-based payment award, options, forfeitures in period, weighted average exercise price for the quarter ending 2020-03-31 was $23.70, a 361.09% increase year-over-year.
- VYOME HOLDINGS, INC. share-based compensation arrangements by share-based payment award, options, forfeitures in period, weighted average exercise price for the quarter ending 2019-03-31 was $5.14, a 20.68% decline year-over-year.
- VYOME HOLDINGS, INC. share-based compensation arrangements by share-based payment award, options, forfeitures in period, weighted average exercise price for the quarter ending 2018-03-31 was $6.48, a 752.63% increase year-over-year.
- VYOME HOLDINGS, INC. share-based compensation arrangements by share-based payment award, options, forfeitures in period, weighted average exercise price for the quarter ending 2017-03-31 was $0.76.
- VYOME HOLDINGS, INC. share-based compensation arrangements by share-based payment award, options, forfeitures in period, weighted average exercise price for fiscal 2020 was $37.74, a 15.11% decline from fiscal 2019.
- VYOME HOLDINGS, INC. share-based compensation arrangements by share-based payment award, options, forfeitures in period, weighted average exercise price for fiscal 2019 was $44.46, a 614.79% increase from fiscal 2018.
- VYOME HOLDINGS, INC. share-based compensation arrangements by share-based payment award, options, forfeitures in period, weighted average exercise price for fiscal 2018 was $6.22, a 0.48% decline from fiscal 2017.
- VYOME HOLDINGS, INC. share-based compensation arrangements by share-based payment award, options, forfeitures in period, weighted average exercise price for fiscal 2017 was $6.25, a 83.28% increase from fiscal 2016.
| Period end | Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price 3 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price 6 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price 9 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price 12 month |
|---|---|---|---|---|
| 2020-12-31 | $37.74 10-K · filed 2021-03-12 | |||
| 2020-09-30 | $37.74 10-Q · filed 2020-11-06 | |||
| 2020-06-30 | $30.03 10-Q · filed 2020-07-30 | |||
| 2020-03-31 | $23.70 10-Q · filed 2020-06-19 | |||
| 2019-12-31 | $44.46 10-K · filed 2020-02-27 | |||
| 2019-09-30 | $45.45 10-Q · filed 2019-11-08 | |||
| 2019-06-30 | $4.89 10-Q · filed 2019-07-24 | |||
| 2019-03-31 | $5.14 10-Q · filed 2019-05-10 | |||
| 2018-12-31 | $6.22 10-K · filed 2019-02-22 | |||
| 2018-09-30 | $6.32 10-Q · filed 2018-11-02 | |||
| 2018-06-30 | $6.53 10-Q · filed 2018-08-02 | |||
| 2018-03-31 | $6.48 10-Q · filed 2018-05-10 | |||
| 2017-12-31 | $6.25 10-K · filed 2018-03-05 | |||
| 2017-09-30 | $5.56 10-Q · filed 2017-11-03 | |||
| 2017-06-30 | $6.14 10-Q · filed 2017-08-02 | |||
| 2017-03-31 | $0.76 10-Q · filed 2017-05-10 | |||
| 2016-12-31 | $3.41 10-K · filed 2017-02-23 | |||
| 2016-09-30 | $2.23 10-Q · filed 2016-11-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |